ISCT

@ISCTglobal

Driving the translation of cellular therapies for the benefit of patients worldwide.

Head Office: Vancouver, Canada
Vrijeme pridruživanja: siječanj 2015.

Tweetovi

Blokirali ste korisnika/cu @ISCTglobal

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ISCTglobal

  1. prije 18 sati

    Last chance to register for the February 6th ISCT Webinar "Gene Therapy & Gene Editing for Hemoglobinopathies: The Basics, The Present & The Future," featuring presentations from Allistair Abraham, Erica Esrick and Sandeep Soni. REGISTER TODAY at .

    Poništi
  2. proslijedio/la je Tweet
    Poništi
  3. proslijedio/la je Tweet
    4. velj

    Stem cells and EV peeps! let's start planning Parisian trip 🍷🥐🍾 👇👇👇

    Poništi
  4. proslijedio/la je Tweet
    1. velj

    Bruce Levine - next ISCT President - illustrating different organizational models for cellular therapy manufacturing. Stresses the need for comparative studies in these simulations. ⁩ ⁦⁩ ⁦⁩ ⁦

    Poništi
  5. proslijedio/la je Tweet

    GSEV president will be chairing the EV Plenary Session at in May!

    Poništi
  6. proslijedio/la je Tweet
    3. velj

    Hey Twitterverse! I'll be speaking at the Plenary Session on at the meeting in Paris, 27-30th May 2020. Please help this spread the word. Drop me a DM if you are attending. I'm planning a day trip for us Tweeps!

    Poništi
  7. proslijedio/la je Tweet
    29. sij
    Poništi
  8. proslijedio/la je Tweet
    31. sij

    ! The HESI CT-TRACS Committee will be presenting a session titled "Imaging Cellular Therapeutics" at the Meeting on Friday, May 29, 2020 from 10:45 AM – 12:15 PM in Paris France. Learn more here:

    Poništi
  9. 30. sij

    Only 1 week away! ISCT Webinar "Gene Therapy and Gene Editing for Hemoglobinopathies: The Basics, The Present, and The Future." Hear from top minds in the field as they discuss the current therapeutic landscape for sickle cell disease & thalassemia.

    Poništi
  10. proslijedio/la je Tweet

    Press release: New CGT Catapult CEO Matthew Durdy brings continuity and ambition for further impact. The appointment comes as CGT Catapult prepares to accelerate innovation, growth and productivity, where needed in the UK. Read the full announcement 📣:

    Poništi
  11. 27. sij

    REGISTER TODAY for the ISCT Immuno-Gene Therapy Committee's Feb 6th webinar "Gene Therapy and Gene Editing for Hemoglobinopathies," and gain access to a comprehensive ISCT patient resource FREE-OF-CHARGE!

    Poništi
  12. proslijedio/la je Tweet
    21. sij

    Commercialization Signature Series - Clinical Breakthroughs Transforming the Standard of Care

    Poništi
  13. proslijedio/la je Tweet
    21. sij

    Kurt Gunter “if you’re in cancer immunotherapy you’re going to see competition for patients” suggests Randomized Clinical Trials will give way to Synthetic Comparator Trial Data

    Poništi
  14. proslijedio/la je Tweet
    21. sij
    Poništi
  15. 21. sij

    That's a wrap! Miguel Forte, Chief Commercialization Officer closing out the 2020 Commercialization Signature Series. Thanks to all the speakers and attendees for a great day of discussion.

    Poništi
  16. proslijedio/la je Tweet
    21. sij

    CEO presenting perspectives on at Commercialization Signature Series

    Poništi
  17. proslijedio/la je Tweet
    20. sij

    ISCT 2020 Paris, France Program Schedule

    Poništi
  18. proslijedio/la je Tweet
    20. sij

    looking forward to delivering the keynote tomorrow at the ISCT Commercial Signature series in Miami. Will share my thoughts on the future of cell therapies for the next decade

    Poništi
  19. proslijedio/la je Tweet
    19. sij
    Poništi
  20. proslijedio/la je Tweet
    17. sij

    Annual Meeting - Special discounted academic registration rates for LATAM and India

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·